Related Experiment Video
Updated: Jun 3, 2026

Comparing the Affinity of GTPase-binding Proteins using Competition Assays
Published on: October 8, 2015
The small GTPase Rac1 is a novel binding partner of Bcl-2 and stabilizes its antiapoptotic activity
Rathiga Velaithan1, Jia Kang, Jayshree L Hirpara
1Department of Physiology, Yong Loo Lin School of Medicine, Singapore.
Abstract:
The small GTPase Rac1 is involved in the activation of the reduced NAD phosphate oxidase complex resulting in superoxide production. We recently showed that Bcl-2 overexpression inhibited apoptosis in leukemia cells by creating a pro-oxidant intracellular milieu, and that inhibiting intracellular superoxide production sensitized Bcl-2-overexpressing cells to apoptotic stimuli. We report here that silencing and functional inhibition of Rac1 block Bcl-2-mediated increase in intracellular superoxide levels in tumor cells. Using confocal, electron microscopy and coimmunoprecipitation, as well as glutathione S-transferase-fusion proteins, we provide evidence for a colocalization and physical interaction between the 2 proteins. This interaction is blocked in vitro and in vivo by the BH3 mimetics as well as by synthetic Bcl-2 BH3 domain peptides. That this interaction is functionally relevant is supported by the ability of the Bcl-2 BH3 peptide as well as the silencing and functional inhibition of Rac1 to inhibit intracellular superoxide production as well as overcome Bcl-2-mediated drug resistance in human leukemia cells and cervical cancer cells. Notably, the interaction was observed in primary cells derived from patients with B-cell lymphoma overexpressing Bcl-2 but not in noncancerous tissue. These data provide a novel facet in the biology of Bcl-2 with potential implications for targeted anticancer drug design.
Insights
Bcl-2 overexpression promotes cancer by increasing superoxide via Rac1 interaction. Inhibiting this interaction with BH3 mimetics or Rac1 inhibition overcomes drug resistance in leukemia and cervical cancer cells.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Bcl-2 overexpression inhibits apoptosis and promotes a pro-oxidant state in cancer cells.
- Rac1 (small GTPase) activates NADPH oxidase, leading to superoxide production.
- Previous work showed inhibiting superoxide production sensitizes Bcl-2-overexpressing cells to apoptosis.
Purpose of the Study:
- To investigate the role of Rac1 in Bcl-2-mediated superoxide production and drug resistance.
- To elucidate the interaction between Bcl-2 and Rac1.
- To evaluate the therapeutic potential of targeting this interaction.
Main Methods:
- Silencing and functional inhibition of Rac1.
- Confocal and electron microscopy.
- Coimmunoprecipitation and GST-pull down assays.
- Treatment with BH3 mimetics and Bcl-2 BH3 domain peptides.
- Assessment of superoxide levels and drug resistance in cancer cell lines and primary patient cells.
Main Results:
- Silencing or inhibiting Rac1 blocked Bcl-2-mediated increases in intracellular superoxide.
- Bcl-2 and Rac1 were found to colocalize and physically interact.
- This interaction was inhibited by BH3 mimetics and Bcl-2 BH3 peptides.
- BH3 peptides and Rac1 inhibition reduced superoxide production and overcame Bcl-2-mediated drug resistance.
- The Bcl-2/Rac1 interaction was observed in primary B-cell lymphoma cells but not in normal tissues.
Conclusions:
- Rac1 is a key mediator of Bcl-2-induced superoxide production and drug resistance.
- The physical interaction between Bcl-2 and Rac1 is a novel target for anticancer drug development.
- Targeting the Bcl-2/Rac1 interaction offers a potential strategy for overcoming therapeutic resistance in various cancers.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Cell Polarization by Rho Proteins
The Intrinsic Apoptotic Pathway
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
GTPases and their Regulation
Large G-proteins, also known...
GTPases and their Regulation
Large G-proteins, also known...

